UY32624A - Procedimiento y composición para mejorar la absorción de agentes terapéuticos - Google Patents
Procedimiento y composición para mejorar la absorción de agentes terapéuticosInfo
- Publication number
- UY32624A UY32624A UY0001032624A UY32624A UY32624A UY 32624 A UY32624 A UY 32624A UY 0001032624 A UY0001032624 A UY 0001032624A UY 32624 A UY32624 A UY 32624A UY 32624 A UY32624 A UY 32624A
- Authority
- UY
- Uruguay
- Prior art keywords
- absorption
- procedure
- composition
- improve
- therapeutic agents
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/143—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Inorganic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Un comprimido con un perfil de disolución mejorado para un ingrediente medicinalmente activo tal como aspirina y procedimientos para fabricar el comprimido. El comprimido comprende una mezcla de cristales de un ingrediente medicinalmente activo y un coadyuvante de disolución tal como carbonato de sodio o calcio que recubre los cristales al molerlos conjuntamente. La mezcla se prensa después para moldear comprimidos que tienen un perfil de disolución mejorado para el ingrediente medicinalmente activo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US12/387,977 US11135188B2 (en) | 2009-05-11 | 2009-05-11 | Method and composition to improve absorption of therapeutic agents |
Publications (1)
Publication Number | Publication Date |
---|---|
UY32624A true UY32624A (es) | 2010-12-31 |
Family
ID=43062708
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001032624A UY32624A (es) | 2009-05-11 | 2010-05-11 | Procedimiento y composición para mejorar la absorción de agentes terapéuticos |
Country Status (15)
Country | Link |
---|---|
US (1) | US11135188B2 (es) |
EP (1) | EP2429502B1 (es) |
AR (1) | AR076864A1 (es) |
BR (1) | BRPI1013509A2 (es) |
CA (1) | CA2761678A1 (es) |
CL (1) | CL2011002807A1 (es) |
CO (1) | CO6460753A2 (es) |
EA (1) | EA201171399A1 (es) |
HU (1) | HUE043173T2 (es) |
MX (1) | MX2011011928A (es) |
PL (1) | PL2429502T3 (es) |
PT (1) | PT2429502T (es) |
SI (1) | SI2429502T1 (es) |
UY (1) | UY32624A (es) |
WO (1) | WO2010132095A1 (es) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US11135188B2 (en) | 2009-05-11 | 2021-10-05 | Bayer Healthcare Llc | Method and composition to improve absorption of therapeutic agents |
WO2014122195A1 (en) * | 2013-02-06 | 2014-08-14 | Hermes Arzneimittel Gmbh | Pharmaceutical compositions incorporating low-dose drugs |
US10195153B2 (en) | 2013-08-12 | 2019-02-05 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded immediate release abuse deterrent pill |
WO2015095391A1 (en) | 2013-12-17 | 2015-06-25 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
US9492444B2 (en) | 2013-12-17 | 2016-11-15 | Pharmaceutical Manufacturing Research Services, Inc. | Extruded extended release abuse deterrent pill |
PT3154528T (pt) | 2014-06-11 | 2023-06-22 | SpecGx LLC | Composições secas por pulverização possuindo diferentes perfis de dissolução e processos para a sua preparação |
CA2955229C (en) | 2014-07-17 | 2020-03-10 | Pharmaceutical Manufacturing Research Services, Inc. | Immediate release abuse deterrent liquid fill dosage form |
EP3209282A4 (en) | 2014-10-20 | 2018-05-23 | Pharmaceutical Manufacturing Research Services, Inc. | Extended release abuse deterrent liquid fill dosage form |
US11197830B2 (en) * | 2019-02-27 | 2021-12-14 | Aft Pharmaceuticals Limited | Pharmaceutical composition containing acetaminophen and ibuprofen |
MX2023005639A (es) * | 2020-11-13 | 2023-09-22 | Bayer Healthcare Llc | Comprimidos de capa doble orales que comprenden acido acetilsalicilico y pseudoefedrina, metodos para preparar y utilizar los mismos. |
Family Cites Families (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB191225486A (en) | 1912-11-06 | 1913-04-24 | Herbert Sefton-Jones | Manufacture and Production of Improved Pharmaceutical Preparations. |
US2293359A (en) | 1941-01-08 | 1942-08-18 | Quisling Sverre | Acetyl salicylic acid preparation |
FI89004C (fi) | 1988-02-16 | 1993-08-10 | Pertti J Neuvonen | Anvaendning av tillsatsmedel foer oekning av absorptionshastigheten av laekemedel i orala laekemedelspreparat |
RU2099058C1 (ru) | 1992-06-15 | 1997-12-20 | Институт химии твердого тела и переработки минерального сырья СО РАН | Способ получения твердой быстрорастворимой дисперсной системы, содержащей ацетилсалициловую кислоту |
US5665388A (en) | 1995-11-13 | 1997-09-09 | Health Corporation | Method for preparation of an alkaline and aspirin combination compound |
ZA987800B (en) | 1997-08-27 | 1999-06-09 | Hexal Ag | Pharmaceutical composition of meloxicam |
US8231899B2 (en) * | 1998-09-10 | 2012-07-31 | Nycomed Danmark Aps | Quick release pharmaceutical compositions of drug substances |
US20030180352A1 (en) * | 1999-11-23 | 2003-09-25 | Patel Mahesh V. | Solid carriers for improved delivery of active ingredients in pharmaceutical compositions |
RU2170582C1 (ru) | 2000-02-17 | 2001-07-20 | Институт химии твердого тела и механохимии СО РАН | Способ получения быстрорастворимой таблетированной формы ацетилсалициловой кислоты |
WO2005105102A1 (en) | 2004-05-04 | 2005-11-10 | Equitech Corporation | Improved nsaid composition |
US8216610B2 (en) | 2004-05-28 | 2012-07-10 | Imaginot Pty Ltd. | Oral paracetamol formulations |
GEP20094671B (en) * | 2004-06-29 | 2009-04-27 | Nycomed Danmark Aps | Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
ES2409347T3 (es) * | 2004-10-21 | 2013-06-26 | Aptalis Pharmatech, Inc. | Composiciones farmacéuticas de sabor enmascarado con agentes porogénicos gastrosolubles |
CA2629904C (en) | 2005-11-28 | 2018-07-10 | Imaginot Pty Ltd. | Oral therapeutic compound delivery system |
US11135188B2 (en) | 2009-05-11 | 2021-10-05 | Bayer Healthcare Llc | Method and composition to improve absorption of therapeutic agents |
-
2009
- 2009-05-11 US US12/387,977 patent/US11135188B2/en active Active
-
2010
- 2010-05-10 HU HUE10775187A patent/HUE043173T2/hu unknown
- 2010-05-10 BR BRPI1013509A patent/BRPI1013509A2/pt not_active IP Right Cessation
- 2010-05-10 MX MX2011011928A patent/MX2011011928A/es unknown
- 2010-05-10 PT PT10775187T patent/PT2429502T/pt unknown
- 2010-05-10 EP EP10775187.7A patent/EP2429502B1/en active Active
- 2010-05-10 WO PCT/US2010/001375 patent/WO2010132095A1/en active Application Filing
- 2010-05-10 CA CA2761678A patent/CA2761678A1/en not_active Abandoned
- 2010-05-10 SI SI201031864T patent/SI2429502T1/sl unknown
- 2010-05-10 EA EA201171399A patent/EA201171399A1/ru unknown
- 2010-05-10 PL PL10775187T patent/PL2429502T3/pl unknown
- 2010-05-11 UY UY0001032624A patent/UY32624A/es not_active Application Discontinuation
- 2010-05-11 AR ARP100101627A patent/AR076864A1/es unknown
-
2011
- 2011-11-10 CL CL2011002807A patent/CL2011002807A1/es unknown
- 2011-11-11 CO CO11153958A patent/CO6460753A2/es not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL2429502T3 (pl) | 2019-07-31 |
PT2429502T (pt) | 2019-03-29 |
US20100286100A1 (en) | 2010-11-11 |
CA2761678A1 (en) | 2010-11-18 |
SI2429502T1 (sl) | 2019-05-31 |
CO6460753A2 (es) | 2012-06-15 |
MX2011011928A (es) | 2011-12-06 |
WO2010132095A1 (en) | 2010-11-18 |
EP2429502A4 (en) | 2012-10-24 |
EA201171399A1 (ru) | 2012-05-30 |
EP2429502A1 (en) | 2012-03-21 |
US11135188B2 (en) | 2021-10-05 |
WO2010132095A8 (en) | 2011-07-07 |
BRPI1013509A2 (pt) | 2016-04-05 |
CL2011002807A1 (es) | 2012-06-15 |
AR076864A1 (es) | 2011-07-13 |
EP2429502B1 (en) | 2018-12-26 |
HUE043173T2 (hu) | 2019-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY32624A (es) | Procedimiento y composición para mejorar la absorción de agentes terapéuticos | |
CR10349A (es) | Tabletas de paracetamol de liberacion rapida | |
CR11625A (es) | Formulacion de capsula | |
CR11709A (es) | Preparacion solida de desintegracion oral | |
CL2011000170A1 (es) | Composicion farmaceutica solida y estabilizada que comprende un ingrediente farmaceuticamente activo, oxido de titanio y un plastificante; procedimiento para estabilizar la composicion farmaceutica durante una irradiacion luminosa. | |
CL2013000063A1 (es) | Un método para tratar a un sujeto que comprende administrar n-etil-n-fenil1,2-dihidroxi-4-hodroxi-5-cloro-1-metil-2-oxoquinolina-3-carboxamida opcionalmente deuterada, para el tratamiento de una enfermedad autoinmunitaria; una mezcla de los mismos; composición farmaceutica y su proceso de preparacion. | |
BR112012020731A2 (pt) | pastilhas gelatinosas suaves com nicotina. | |
PE20150083A1 (es) | Formulacion de ibuprofeno inyectable | |
MX2019008817A (es) | Formulacion de liberacion prolongada para reducir la frecuencia de miccion y metodo de uso de la misma. | |
DOP2012000277A (es) | Comprimido de desintegracion por via oral que contiene acarbosa | |
EA201690679A1 (ru) | Стабильная фармацевтическая композиция, содержащая амлодипин и валсартан | |
CY1122387T1 (el) | Διπλης χρησης δισκια στοματικης φαρμακευτικης συνθεσης θειικων αλατων και μεθοδοι χρησης αυτων | |
ES2720869T3 (es) | Composiciones farmacéuticas de sevelámero | |
UY33348A (es) | Compuestos de furopiridina y usos de los mismos | |
AR062925A1 (es) | Metodo para fabricar tabletas que contienen agentes farmacologicamente activos | |
AR083095A1 (es) | Cocristal de aprepitant l-prolina y composicion farmaceutica | |
NI201200196A (es) | Agentes terapéuticos 976 | |
NI201500027A (es) | Formulación de comprimidos compuestos de dos fases que comprenden atorvastatina, irbesartan y carbonato de magnesio. | |
CL2016002655A1 (es) | Composición farmacéutica para el tratamiento de alopatías relacionadas con el dolor, usando como agente activo al ketorolaco trometamina y clorhidrato de tramadol | |
WO2010042600A3 (en) | Photo-activatable therapeutic agents and methods of using | |
AR094203A1 (es) | Formulacion farmaceutica en n-[5-[2-(3,5-dimetoxifenil)etil]-2h-pirazol-3-il]-4-[(3r,5s)-3,5-dimetilpiperazin-1-il]benzamida | |
MX359106B (es) | Composicion farmaceutica inyectable de dexketoprofeno y tramadol. | |
IN2014CN04119A (es) | ||
ECSP11011212A (es) | Nueva asociación de ingredientes activos que contienen un fármaco antiinflamatorio, no esteroideo y un derivado de colchicósido | |
GT200700005A (es) | Composicion farmaceutica estable de carisoprodol y meloxicam |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
109 | Application deemed to be withdrawn |
Effective date: 20181129 |